BriaCell Therapeutics Statistics

Total Valuation

BCTX has a market cap or net worth of $18.76 million. The enterprise value is $12.75 million.

Market Cap	18.76M
Enterprise Value	12.75M

Important Dates

The next estimated earnings date is Monday, March 17, 2025, after market close.

Earnings Date	Mar 17, 2025
Ex-Dividend Date	n/a

Share Statistics

BCTX has 3.71 million shares outstanding. The number of shares has increased by 21.51% in one year.

Current Share Class	3.71M
Shares Outstanding	3.71M
Shares Change (YoY)	+21.51%
Shares Change (QoQ)	+49.04%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	3.20M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	5.05
P/TBV Ratio	4.88
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.65

Current Ratio	1.65
Quick Ratio	1.65
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -536.81% and return on invested capital (ROIC) is -601.59%.

Return on Equity (ROE)	-536.81%
Return on Assets (ROA)	-129.07%
Return on Invested Capital (ROIC)	-601.59%
Return on Capital Employed (ROCE)	-552.55%
Revenue Per Employee	n/a
Profits Per Employee	-$1.04M
Employee Count	16
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -91.38% in the last 52 weeks. The beta is 1.87, so BCTX's price volatility has been higher than the market average.

Beta (5Y)	1.87
52-Week Price Change	-91.38%
50-Day Moving Average	7.02
200-Day Moving Average	12.72
Relative Strength Index (RSI)	40.98
Average Volume (20 Days)	965,056

Short Selling Information

The latest short interest is 94,836, so 2.56% of the outstanding shares have been sold short.

Short Interest	94,836
Short Previous Month	1.62M
Short % of Shares Out	2.56%
Short % of Float	2.96%
Short Ratio (days to cover)	1.28

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-29.98M
Pretax Income	-6.04M
Net Income	-16.60M
EBITDA	-29.87M
EBIT	-29.98M
Earnings Per Share (EPS)	-$13.02

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	5.79M
Total Debt	n/a
Net Cash	5.79M
Net Cash Per Share	$1.56
Equity (Book Value)	3.71M
Book Value Per Share	1.68
Working Capital	3.23M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$23.48 million and capital expenditures -$456,801, giving a free cash flow of -$23.93 million.

Operating Cash Flow	-23.48M
Capital Expenditures	-456,801
Free Cash Flow	-23.93M
FCF Per Share	-$6.45

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BCTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.51%
Shareholder Yield	-21.51%
Earnings Yield	-88.47%
FCF Yield	-127.59%

Analyst Forecast

The average price target for BCTX is $32.00, which is 623.98% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$32.00
Price Target Difference	623.98%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 29, 2025. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	Jan 29, 2025
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a